Takeaway

• Higher baseline plasma levels of the SARS-CoV-2 nucleocapsid (N) protein antigen in hospitalised patients with COVID-19 are associated with clinical severity.

Why this matters

• There is a need for biomarkers of COVID-19's clinical severity to guide treatment.
• This is among the first studies of the potential value of SARS-CoV-2...